Although the role of STAT3 in ALL has not been well determined, pieces of evidence highlight the potent anti-proliferative and anti-tumor inhibition of STAT3 in B-ALL cells in clinical studies (Belton et al., 2016). Here, STAT3 is linked to neoplasm.